Overview
The marketing authorisation for RevitaCAM has been withdrawn at the request of the marketing authorisation holder.
RevitaCAM : EPAR - Summary for the public
English (EN)
(689.07 KB - PDF)View
български (BG)
(718.93 KB - PDF)
español (ES)
(686.5 KB - PDF)
čeština (CS)
(714.35 KB - PDF)
dansk (DA)
(684.23 KB - PDF)
Deutsch (DE)
(711.64 KB - PDF)
eesti keel (ET)
(683.68 KB - PDF)
ελληνικά (EL)
(768.88 KB - PDF)
français (FR)
(689.86 KB - PDF)
italiano (IT)
(684.55 KB - PDF)
latviešu valoda (LV)
(711.22 KB - PDF)
lietuvių kalba (LT)
(713.37 KB - PDF)
magyar (HU)
(714.59 KB - PDF)
Malti (MT)
(723.84 KB - PDF)
Nederlands (NL)
(685.59 KB - PDF)
polski (PL)
(717.45 KB - PDF)
português (PT)
(685.71 KB - PDF)
română (RO)
(712.26 KB - PDF)
slovenčina (SK)
(717.59 KB - PDF)
slovenščina (SL)
(702.25 KB - PDF)
Suomi (FI)
(707.79 KB - PDF)
svenska (SV)
(684.22 KB - PDF)
Product information
RevitaCAM : EPAR - Product Information
English (EN)
(486.61 KB - PDF)View
български (BG)
(521.31 KB - PDF)
español (ES)
(492.99 KB - PDF)
čeština (CS)
(501.25 KB - PDF)
dansk (DA)
(488.28 KB - PDF)
Deutsch (DE)
(494.63 KB - PDF)
eesti keel (ET)
(478.84 KB - PDF)
ελληνικά (EL)
(553.97 KB - PDF)
français (FR)
(499.63 KB - PDF)
hrvatski (HR)
(551.39 KB - PDF)
íslenska (IS)
(491.8 KB - PDF)
italiano (IT)
(490.17 KB - PDF)
latviešu valoda (LV)
(497.13 KB - PDF)
lietuvių kalba (LT)
(501.29 KB - PDF)
magyar (HU)
(504.12 KB - PDF)
Malti (MT)
(504.9 KB - PDF)
Nederlands (NL)
(350.42 KB - PDF)
norsk (NO)
(352.92 KB - PDF)
polski (PL)
(515.68 KB - PDF)
português (PT)
(507.88 KB - PDF)
română (RO)
(639.12 KB - PDF)
slovenčina (SK)
(511.57 KB - PDF)
slovenščina (SL)
(492.55 KB - PDF)
Suomi (FI)
(486.93 KB - PDF)
svenska (SV)
(488.96 KB - PDF)
Latest procedure affecting product information: T/0006
05/10/2015
RevitaCAM : EPAR - All Authorised presentations
English (EN)
(146.35 KB - PDF)View
български (BG)
(164.54 KB - PDF)
español (ES)
(151.74 KB - PDF)
čeština (CS)
(167.53 KB - PDF)
dansk (DA)
(150.89 KB - PDF)
Deutsch (DE)
(151.51 KB - PDF)
eesti keel (ET)
(151.17 KB - PDF)
ελληνικά (EL)
(171.71 KB - PDF)
français (FR)
(151.53 KB - PDF)
hrvatski (HR)
(161.23 KB - PDF)
íslenska (IS)
(151.73 KB - PDF)
italiano (IT)
(151.41 KB - PDF)
latviešu valoda (LV)
(170.63 KB - PDF)
lietuvių kalba (LT)
(167.47 KB - PDF)
magyar (HU)
(165.52 KB - PDF)
Malti (MT)
(170.14 KB - PDF)
Nederlands (NL)
(152.57 KB - PDF)
norsk (NO)
(150.28 KB - PDF)
polski (PL)
(169.01 KB - PDF)
português (PT)
(151.93 KB - PDF)
română (RO)
(168.91 KB - PDF)
slovenčina (SK)
(167.51 KB - PDF)
slovenščina (SL)
(157.36 KB - PDF)
Suomi (FI)
(151.63 KB - PDF)
svenska (SV)
(156.69 KB - PDF)
Product details
- Name of medicine
- RevitaCAM
- Active substance
- meloxicam
- International non-proprietary name (INN) or common name
- meloxicam
- Species
- Dogs
- Anatomical therapeutic chemical veterinary (ATCvet) code
- QM01AC06
Pharmacotherapeutic group
OxicamsTherapeutic indication
Alleviation of inflammation and pain in both acute and chronic musculoskeletal disorders in dogs.
Assessment history
RevitaCAM : EPAR - Procedural steps taken and scientific information after authorisation
English (EN)
(201.25 KB - PDF)View
This page was last updated on